• Following a previous press release regarding our anti-cancer developments, we received e-mails and telephone calls requesting more information about our developments from the heads of two of the largest pharmaceutical companies in the world. In order to protect our intellectual property until the patent is issued, we politely refused to convey any additional information that might jeopardize our position. • Our most recent anti-breast cancer antibody test results will be presented at the AACR Conference to be held April 16-20, 2016 in New Orleans. We have been advised that some 20,000 people will be at the conference. We will provide an update after the conference.BIEI
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.